Verträglichkeit und wirksamkeit einer 5%igen versus einer 10%igen i.v.-immunglobulinpräparation bei erwachsenen patienten mit immunthrombozytopenie - Eine pilotstudie

Infusionstherapie und Transfusionsmedizin

Volumn 23, Issue SUPPL. 4, 1996, Pages 104-108

  Wehmeier, A ^a   Zahner, J ^a   Schneider, W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Autoimmune thrombocytopenia; Immunoglobulin therapy (safety, efficacy)

Indexed keywords

AZATHIOPRINE; GLUCOCORTICOID; IMMUNOGLOBULIN G;

ADULT; AGED; AUTOIMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NAUSEA; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA;

EID: 0030458276     PISSN: 14245485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Berchtold P, Wenger M: Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: Their clinical significance and response to treatment. Blood 1993;81:1246-1250.
2. Imbach PA: Harmful and beneficial antibodies in immune thrombocytopenic purpura.Clin Exp Immunol 1994;97(suppl 1):25-30.
3. Friend PJ, McCarthy LJ, Filo RS, Leapman SB, Pescovitz MD, Lumeng L, Pound D, Arnold K, Hoffman R, McFarland JG, Aster, RH: Transmission of idiopathic (autoimmune) thrombocytopenic purpura by liver transplantation. N Engl J Med 1990;323:807-811.
4. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T: High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991;77:31-33.
5. Belluci S, Charpak Y, Chastang C, Tobelem G. The Cooperative Group on Immune Thrombocytopenic Purpura: Low doses vs. conventional doses of corticoids in immune thrombocytopenic purpura (ITP): Results of a randomized trial in 160 children, 223 adults. Blood 1988;71:1165-1169.
6. Kirchner JT: Acute and chronic immune thrombocytopenic purpura: Disorders that differ in more than duration. Postgrad Med 1992;92:112-126.
7. Ballow M: Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue disease. Cancer 1991;68:1430-1436.
8. Mitterer M, Pescosta N, Vogtseder W, Mair M, Coser P: Two episodes of aseptic meningitis during intravenous immunoglobulin therapy of idiopathic thrombocytopenic purpura. Ann Hematol 1993;67:151-152.
9. Gunsilius E, Seifried E: Therapie der Autoimmunthrombozytopenie des Erwachsenen. Infusionsther Transfusionsmed 1993;20(suppl 1):87-98.
10. Godeau B, Lesage S, Divine M, Wirquin V, Farcet JP, Bierling P: Treatment of adult chronic autoimmune thrombocytopenic purpura with repeated high-dose intravenous immunoglobulin. Blood 1993;82:1415-1421.
11. Finger H: Zur Unschädlichkeit von Immunglobulinpräparaten. Immun Infekt 1995;23:117-118.